Blog
01-04-2023Cross-posted from FDA News Release [On December 22, 2022], the U.S. Food and Drug Administration approved Sunlenca (lenacapavir), a new type of antiretroviral…
FDA News Release
FDA Approves New HIV Drug for Adults with Limited Treatment Options - Blog
FDA Approves First Two-drug Complete Regimen for HIV-infected Patients Who Have Never Received Antiretroviral Treatment 04-09-2019Cross-posted from FDA NewsroomOn April 8, 2019, the U.S. Food and Drug Administration approved Dovato (dolutegravir and lamivudine), as a complete regimen for… - Blog
FDA approves Epclusa for treatment of chronic Hepatitis C virus infection 06-30-2016First regimen to treat all six major HCV genotypesThe U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus… - Blog
Califf, FDA top officials call for sweeping review of agency opioids policies 02-05-2016Editor’s Note: Reducing opioid misuse not only reduces deaths from overdose but is also key to reducing new HIV and viral hepatitis infections among persons… - Blog
FDA updates blood donor deferral policy to reflect the most current scientific evidence and continue to ensure the safety of the U.S. blood supply 12-21-2015 - Blog
FDA Commissioner Margaret A. Hamburg's statement on FDA’s blood donor deferral policy for men who have sex with men 12-23-2014The U.S. Food and Drug Administration is a science-based regulatory agency that works to protect and promote the public health. In this role, it is our… - Blog
FDA approves Sovaldi for chronic hepatitis C 12-09-2013Drug is third with breakthrough therapy designation to receive FDA approvalThe U.S. Food and Drug Administration today approved Sovaldi (sofosbuvir) to treat…